Literature DB >> 2378447

The immune response to phase I and phase II Coxiella burnetii antigens as measured by western immunoblotting.

J M Blondeau1, J C Williams, T J Marrie.   

Abstract

To determine the utility of Western immunoblotting in distinguishing chronic Q fever from acute Q fever, we first examined serum samples from individuals who had no antibodies to Coxiella burnetii by either the indirect immunofluorescence antibody test or by the enzyme-linked immunosorbent assay. In these subjects, the IgG fraction in low dilutions of serum (1:8, 1:16) reacted with as many as 10 proteins in phase I and phase II antigens. This number of reacting bands seen in Western blots was reduced by using serum in a dilution of 1:1024. In contrast, IgA antibodies were uncommon even at low dilutions. Likewise, IgA antibodies were infrequently observed in patients with acute Q fever. However, in chronic Q fever there were many IgA antibodies to phase I and phase II proteins. Antibodies to phase I proteins were more common than those to phase II proteins. Several antigenic protein bands were recognized only by serum from chronic Q fever patients. Three of these antigens had molecular masses of, respectively, 50 kDa, 80 kDa, and 160 kDa. Serial serum samples from patients with chronic Q fever revealed that the number of antigens recognized by the IgA fraction decreased after the initiation of antibiotic therapy. The decline was faster for antibodies to phase II proteins. We conclude that immunoblotting is useful in the diagnosis of chronic Q fever.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2378447     DOI: 10.1111/j.1749-6632.1990.tb42220.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  9 in total

Review 1.  Diagnosis of Q fever.

Authors:  P E Fournier; T J Marrie; D Raoult
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

2.  Coxiella burnetii - Pathogenic Agent of Q (Query) Fever.

Authors:  Lutz Gürtler; Ursula Bauerfeind; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Ruth Offergeld; Georg Pauli; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen
Journal:  Transfus Med Hemother       Date:  2013-12-23       Impact factor: 3.747

3.  Serological cross-reactions between Bartonella quintana, Bartonella henselae, and Coxiella burnetii.

Authors:  B La Scola; D Raoult
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

4.  Animals with Coxiella burnetii infection demonstrate a Western immunoblot profile of chronic Q fever in humans.

Authors:  T Marrie; L Yates
Journal:  Can J Infect Dis       Date:  1996-01

Review 5.  Q fever.

Authors:  M Maurin; D Raoult
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

6.  Cell-mediated and humoral immune responses induced by scarification vaccination of human volunteers with a new lot of the live vaccine strain of Francisella tularensis.

Authors:  D M Waag; A Galloway; G Sandstrom; C R Bolt; M J England; G O Nelson; J C Williams
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

7.  Increases in the levels of Coxiella burnetii-specific immunoglobulin G1 and G3 antibodies in acute Q fever and chronic Q fever.

Authors:  C Capo; I Iorgulescu; M Mutillod; J L Mege; D Raoult
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

8.  Monoclonal antibody based capture ELISA/ELIFA for detection of Coxiella burnetii in clinical specimens.

Authors:  D Thiele; M Karo; H Krauss
Journal:  Eur J Epidemiol       Date:  1992-07       Impact factor: 8.082

Review 9.  A comparative view of Rickettsia tsutsugamushi and the other groups of rickettsiae.

Authors:  A Tamura; H Urakami; N Ohashi
Journal:  Eur J Epidemiol       Date:  1991-05       Impact factor: 8.082

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.